Mutual Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$245K Sell
3,058
-5
-0.2% -$412 0.01% 1202
2025
Q4
$261K Sell
3,063
-108
-3% -$8.86K 0.01% 1139
2025
Q3
$243K Sell
3,171
-110
-3% -$8.6K 0.01% 1145
2025
Q2
$262K Sell
3,281
-217
-6% -$16.2K 0.01% 1022
2025
Q1
$266K Sell
3,498
-218
-6% -$15.6K 0.01% 932
2024
Q4
$260K Sell
3,716
-110
-3% -$7.7K 0.01% 937
2024
Q3
$269K Buy
+3,826
New +$278K 0.01% 946
2024
Q2
Sell
-3,402
Closed -$325K 1104
2024
Q1
$325K Buy
3,402
+765
+29% +$64.3K 0.01% 837
2023
Q4
$201K Buy
+2,637
New +$183K 0.01% 966
2023
Q3
Sell
-3,123
Closed -$295K 999
2023
Q2
$295K Buy
3,123
+553
+22% +$48.1K 0.01% 811
2023
Q1
$213K Sell
2,570
-131
-5% -$10.3K 0.01% 907
2022
Q4
$202K Buy
+2,701
New +$208K 0.01% 876
2022
Q3
Sell
-2,161
Closed -$205K 891
2022
Q2
$205K Sell
2,161
-270
-11% -$28K 0.01% 785
2022
Q1
$286K Buy
2,431
+66
+3% +$7.4K 0.02% 732
2021
Q4
$306K Buy
2,365
+45
+2% +$5.25K 0.02% 737
2021
Q3
$263K Buy
2,320
+360
+18% +$41.1K 0.02% 748
2021
Q2
$203K Buy
+1,960
New +$185K 0.01% 788

Other funds holding EW

Mutual Advisors's EW Position: Q1 2026 in Review

Mutual Advisors reduced its Edwards Lifesciences (EW) stake by 0.16% in Q1 2026, selling an estimated $412 and leaving 3,058 shares worth $245K. The position accounts for 0.01% of the portfolio, ranked #1202.

Mutual Advisors first reported a position in EW in Q2 2021 and has held it in 17 quarters since. The position peaked at $325K in Q1 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Mutual Advisors held 3,058 shares of Edwards Lifesciences worth $245K as of Q1 2026.
  • Mutual Advisors sold 5 Edwards Lifesciences shares in Q1 2026, an estimated $412.
  • Edwards Lifesciences made up 0.01% of Mutual Advisors's portfolio in Q1 2026, its #1202 holding.
  • Mutual Advisors first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 17 quarters since.
  • Mutual Advisors's Edwards Lifesciences position peaked at $325K in Q1 2024.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Mutual Advisors's 13F filing for Q1 2026, filed 4 May 2026.